Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q262610> ?p ?o }
Showing triples 1 to 27 of
27
with 100 triples per page.
- Q262610 subject Q7327916.
- Q262610 subject Q8388296.
- Q262610 subject Q8852392.
- Q262610 abstract "A-86929 is a synthetic compound that acts as a selective dopamine receptor D1 agonist. It was developed as a possible treatment for Parkinson's disease, as well as for other applications such as treatment of cocaine addiction, but while it had reasonable efficacy in humans it also caused dyskinesias and has not been continued. It has mainly been used as its diacetate ester prodrug adrogolide (ABT-431), which has better bioavailability.".
- Q262610 iupacName "9,10-Dihydroxy-2-propyl-4,5,5a(R),6,7,11b(S)-hexahydrobenzo[f]thieno[2,3-c]quinoline".
- Q262610 thumbnail A-86929_structure.png?width=300.
- Q262610 wikiPageWikiLink Q101487.
- Q262610 wikiPageWikiLink Q11085.
- Q262610 wikiPageWikiLink Q18022883.
- Q262610 wikiPageWikiLink Q212527.
- Q262610 wikiPageWikiLink Q3743188.
- Q262610 wikiPageWikiLink Q389934.
- Q262610 wikiPageWikiLink Q415496.
- Q262610 wikiPageWikiLink Q603741.
- Q262610 wikiPageWikiLink Q629444.
- Q262610 wikiPageWikiLink Q7327916.
- Q262610 wikiPageWikiLink Q8388296.
- Q262610 wikiPageWikiLink Q8852392.
- Q262610 iupacname "910".
- Q262610 type ChemicalCompound.
- Q262610 type ChemicalSubstance.
- Q262610 type ChemicalObject.
- Q262610 type Thing.
- Q262610 type Q11173.
- Q262610 comment "A-86929 is a synthetic compound that acts as a selective dopamine receptor D1 agonist. It was developed as a possible treatment for Parkinson's disease, as well as for other applications such as treatment of cocaine addiction, but while it had reasonable efficacy in humans it also caused dyskinesias and has not been continued. It has mainly been used as its diacetate ester prodrug adrogolide (ABT-431), which has better bioavailability.".
- Q262610 label "A-86929".
- Q262610 depiction A-86929_structure.png.